Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Antonio Palumbo Jakub Krejcik Paul G. Richardson Henk M. Lokhorst Monique C Minnema Ulrik Lassen |
| Publication date | August 16, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |